Results 31 to 40 of about 15,582,923 (344)

Accelerating Rare Disease Drug Development: Lessons Learned from Muscular Dystrophy Patient Advocacy Groups

open access: yesTherapeutic Innovation and Regulatory Science, 2020
With scientific and molecular advancements related to disease pathogenesis, advances in gene and stem cell therapies, and the promise of lucrative markets for biopharmaceutical companies, there has been a rapid expansion in the number of potential new ...
Raymond A. Huml   +6 more
semanticscholar   +1 more source

Meaningful Fissures: The Value of Divergent Agendas in Patient Advocacy

open access: yesAmerican Journal of Bioethics, 2020
Patient advocacy organizations emerged in the 1950s to collectivize patient power and promote patient’s shared interests and rights.
J. Richardson, R. Sharp
semanticscholar   +1 more source

Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Progressive familial intrahepatic cholestasis (PFIC) is a spectrum of rare genetic diseases characterized by inadequate bile secretion that requires substantial ongoing care, though little research is published in this area.
Claudia Mighiu   +11 more
doaj   +1 more source

A survey of caregiver burden in those providing informal care for patients with schizophrenia or bipolar disorder with agitation: results from a European study

open access: yesAnnals of General Psychiatry, 2018
Background Agitation is a common feature of bipolar disorder and schizophrenia. Previous research indicates that specific symptoms impact caregiver burden in these conditions, but the impact of agitation on caregiver experience is poorly understood.
Sophee Blanthorn-Hazell   +4 more
doaj   +1 more source

Patient Advocacy for Beginners [PDF]

open access: yesAMA Journal of Ethics, 2011
Though the lack of consensus about the proper role of advocacy in physicians' professional lives makes it unlikely that medical schools will focus on it, those who wish to bring about change can do so without formal training.
openaire   +2 more sources

Barriers to practicing patient advocacy in healthcare setting

open access: yesNursing Open, 2019
To explore barriers to practicing patient advocacy in healthcare setting.
C. Nsiah, Mate Siakwa, Jerry P K Ninnoni
semanticscholar   +1 more source

From observation to action: a qualitative interview study of factors that influence the reporting of observations of unprofessional conduct in healthcare settings

open access: yesBMJ Open Quality
Background Unprofessional behaviour in healthcare settings can undermine patient safety, erode team morale, and if not addressed, negatively impact organisational culture.
William Martinez   +5 more
doaj   +1 more source

Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia

open access: yesBMC Psychiatry, 2018
Background Agitation is a common manifestation of bipolar disorder and schizophrenia which includes symptoms ranging from inner tension and unease to violence and aggression.
Jenna Roberts   +4 more
doaj   +1 more source

US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development

open access: yesClinical and Translational Science, 2020
Drug development guidelines from regulatory authorities provide important information to sponsors on requirements for clinical evidence needed to support approval of new drugs.
Anne Vinther Morant   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy